Patents by Inventor Claire Ferrao

Claire Ferrao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Detection method for
    Patent number: 11976336
    Abstract: A method of detecting the presence of Neisseria gonorrhoeae in a sample. The method involves detecting a first target sequence taken from the NGO1642 gene and/or a second target sequence taken from the NGO1012 gene. The method may involve a step of amplifying the target sequence, and may involve hybridising the target sequence to a nucleic acid probe and identifying hybridisation. The method may involve simultaneous detection of other target sequences, e.g. from other pathogens.
    Type: Grant
    Filed: January 28, 2022
    Date of Patent: May 7, 2024
    Assignee: Binx Health Limited
    Inventors: Danny Filer, Claire Ferrao, Sharon Chadwick
  • DETECTION METHOD FOR NEISSERIA GONORRHOEAE
    Publication number: 20220145374
    Abstract: A method of detecting the presence of Neisseria gonorrhoeae in a sample. The method involves detecting a first target sequence taken from the NGO1642 gene and/or a second target sequence taken from the NGO1012 gene. The method may involve a step of amplifying the target sequence, and may involve hybridising the target sequence to a nucleic acid probe and identifying hybridisation. The method may involve simultaneous detection of other target sequences, e.g. from other pathogens.
    Type: Application
    Filed: January 28, 2022
    Publication date: May 12, 2022
    Inventors: Danny Filer, Claire Ferrao, Sharon Chadwick
  • Detection method for Neisseria gonorrhoeae
    Patent number: 11261501
    Abstract: A method of detecting the presence of Neisseria gonorrhoeae in a sample. The method involves detecting a first target sequence taken from the NGO1642 gene and/or a second target sequence taken from the NGO1012 gene. The method may involve a step of amplifying the target sequence, and may involve hybridising the target sequence to a nucleic acid probe and identifying hybridisation. The method may involve simultaneous detection of other target sequences, e.g. from other pathogens.
    Type: Grant
    Filed: November 14, 2019
    Date of Patent: March 1, 2022
    Assignee: Binx Health Limited
    Inventors: Danny Filer, Claire Ferrao, Sharon Chadwick
  • DETECTION METHOD FOR NEISSERIA GONORRHOEAE
    Publication number: 20200140930
    Abstract: A method of detecting the presence of Neisseria gonorrhoeaein a sample. The method involves detecting a first target sequence taken from the NGO1642 gene and/or a second target sequence taken from the NGO1012 gene. The method may involve a step of amplifying the target sequence, and may involve hybridising the target sequence to a nucleic acid probe and identifying hybridisation. The method may involve simultaneous detection of other target sequences, e.g. from other pathogens.
    Type: Application
    Filed: November 14, 2019
    Publication date: May 7, 2020
    Inventors: Danny Filer, Claire Ferrao, Sharon Chadwick
  • Detection method for
    Patent number: 10519514
    Abstract: A method of detecting the presence of Neisseria gonorrhoeae in a sample. The method involves detecting a first target sequence taken from the NGO1642 gene and/or a second target sequence taken from the NGO1012 gene. The method may involve a step of amplifying the target sequence, and may involve hybridising the target sequence to a nucleic acid probe and identifying hybridisation. The method may involve simultaneous detection of other target sequences, e.g. from other pathogens.
    Type: Grant
    Filed: September 17, 2015
    Date of Patent: December 31, 2019
    Assignee: Atlas Genetics Limited
    Inventors: Danny Filer, Claire Ferrao, Sharon Chadwick
  • DETECTION METHOD FOR NEISSERIA GONORRHOEAE
    Publication number: 20170260572
    Abstract: A method of detecting the presence of Neisseria gonorrhoeae in a sample. The method involves detecting a first target sequence taken from the NGO1642 gene and/or a second target sequence taken from the NGO1012 gene. The method may involve a step of amplifying the target sequence, and may involve hybridising the target sequence to a nucleic acid probe and identifying hybridisation. The method may involve simultaneous detection of other target sequences, e.g. from other pathogens.
    Type: Application
    Filed: September 17, 2015
    Publication date: September 14, 2017
    Applicant: Atlas Genetics Limited
    Inventors: Danny Filer, Claire Ferrao, Sharon Chadwick